South Africa’s medicines regulator SAHPRA said on Friday that it had received documentation for the COVID-19 vaccine developed by China’s Sinovac.
It added in a statement that it would now start evaluating the data and assessing the efficacy of the vaccine.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.